New: NCI-funded clinical trial search
Mednet Logo

How do you incorporate blinatumomab into therapy for a pediatric or AYA patient with isolated CNS relapse of B-ALL, if at all?

Community PollStarted

Do you incorporate blinatumomab into your treatment regimen for pediatric/AYA B-ALL patients with isolated CNS relapse?

13 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer
Mednet MemberInvited Expert
Pediatric Hematology/Oncology · University of Texas MD Anderson Cancer Center
Answered on

I try to prioritize CAR-T in this setting. Getting there depends on logistics such as financial clearance/collection though. If late relapse or if there is a delay in getting CAR-T, would treat with AALL1331 Arm D (with XRT in mtn), substituting block 3 of blina for block 3 on Arm C (to get more CNS penetrating chemotherapy) or following Dr. Maese's excellent article: Maese and Pulsipher, PMID 37311171.

Join for free or sign in to see the full answer